Mood Disorders Clinical Trial
Official title:
The Effects of a Mindful Yoga Program on Mood Symptoms and Stress for Postpartum Women With Depressive Symptoms: a Randomized Controlled Clinical Trial
This is a parallel-group randomized controlled trial. A total of 198 postpartum women with depressive symptoms (EPDS scoresā„8 at baseline) will be recruited and randomized into two groups: 10-week mindful yoga intervention and 10-week psychoeducation program. Clinical assessment of depression, self-report questionnaires and salivary cortisol tests will be performed at baseline, after 10-week intervention, and at 6-month and 12-month follow-ups. The investigators expected that the mindful yoga intervention will reduce depression after 10 weeks compared to psychoeducation. The mindful yoga intervention will further reduce anxiety, stress, improve quality of life and sleep, and steepen diurnal cortisol slopes. These effects will be maintained for at least six months.
Status | Recruiting |
Enrollment | 198 |
Est. completion date | December 31, 2025 |
Est. primary completion date | July 15, 2025 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Postpartum women aged 18-60 years old. - The scores of EPDS = 10. - At least 6 week and up to 1 year after childbirth. - Giving birth to a single full-term healthy baby (gestation between 37-41 weeks, body weight > 2.5kg, APGAR score at 5 minutes > 7). - Fewer than 10 hours of yoga/Qi gong/Tai Chi or mindfulness/meditation practice in the previous 3 months. Exclusion Criteria: - Severe complications after delivery, or their infants are admitted to NICU. - Regular psychiatric follow-up. - Currently taking antipsychotic drugs. - Known pragnancy, or other contraindications to physical exercise (e.g., wound healing situation) according to the body examination by O&G clinicians at 6 weeks after delivery. |
Country | Name | City | State |
---|---|---|---|
Hong Kong | The Hong Kong Polytechnic University | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The Hong Kong Polytechnic University |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Edinburgh Postnatal Depression Scale | Measures postnatal depression. Each item scores 0-3, and the total score ranges from 0 to 30. Higher score means worse depressive symptoms. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | Depression Anxiety Stress Scale-Depression | Measures depressive symptoms. Each item scores 0-3, the total score for depression ranges from 0 to 21. Higher score means worse symptoms of depression. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | Depression Anxiety Stress Scale-Anxiety | Measures anxiety symptoms. Each item scores 0-3, the total score for anxiety ranges from 0 to 21. Higher score means worse symptoms of anxiety. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | Depression Anxiety Stress Scale-Stress | Measures stress symptoms. Each item scores 0-3, the total score for stress ranges from 0 to 21. Higher score means worse symptoms of stress. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | Pittsburgh Sleep Quality Index | Measures sleep quality. There are 8 components scores, and each component score ranges from 0 to 3. Higher score means worse sleep quality. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | 36 Item-Short Form Health Survey Questionnaire | Measures quality of life including physical and mental health. Each item scores 0-100. There are eight subscores ranging from 0 to 100. Higher score means better quality of life. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | Five Facet Mindfulness Questionnaire | Measures the level of mindfulness ability. Each item scores 1-5, and the total score ranges from 42 to 210. Higher score means better mindfulness ability. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | Pregnancy Symptom Inventory | Measures physical pain and fatigue of postpartum women. Each item scores 0-3. The total score ranges from 0 to 24. Higher score means worse pregnancy symptoms. | Baseline, 10 weeks, 6 months and 1 year follow-ups. | |
Secondary | Cortisol concentration level | Measures salivary cortisol concentration at baseline and post-intervention. Higher concentration means higher level of stress and depression. | Baseline and 10 weeks (post-intervention). | |
Secondary | Physical fitness | 6-minute walking test is used for physical fitness measure. The total distance walked during 6 minutes is recorded. Higher score means better fitness. | Baseline and 10 weeks (post-intervention). | |
Secondary | Balance | Single-leg standing test is used to measure the balance. The time to keep the posture is recorded. Higher score means better balance ability. | Baseline and 10 weeks (post-intervention). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Recruiting |
NCT05345392 -
Brain, Emotions, and Mind-Wandering
|
N/A | |
Completed |
NCT05078450 -
Mood Lifters Online for Graduate Students and Young Professionals
|
N/A | |
Not yet recruiting |
NCT04551027 -
Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness
|
N/A | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Active, not recruiting |
NCT02542475 -
Low Field Magnetic Stimulation: Open Label Study.
|
Phase 1/Phase 2 | |
Completed |
NCT00916552 -
Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder
|
Phase 2 | |
Completed |
NCT00202514 -
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
|
Phase 2/Phase 3 | |
Completed |
NCT00217932 -
Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings
|
Phase 2 | |
Completed |
NCT00006517 -
Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)
|
N/A | |
Terminated |
NCT03898843 -
Assisted Animal Therapy: ReAnimal
|
N/A | |
Active, not recruiting |
NCT04358900 -
Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
|
||
Recruiting |
NCT06360562 -
Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)
|
N/A | |
Completed |
NCT05745103 -
Optimizing Behavioral Healthcare Delivery Through Technology
|
N/A | |
Suspended |
NCT03715400 -
Mobile Virtual Positive Experiences for Anhedonia
|
N/A | |
Enrolling by invitation |
NCT03736538 -
Nitrous Oxide- Suicidal Ideation
|
Phase 1 | |
Completed |
NCT04601545 -
The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method
|
N/A | |
Completed |
NCT02566980 -
Biological Triggers of Depression in Pregnancy
|
||
Completed |
NCT03743844 -
Psychosocial Intervention for Women With Mood Disorders Seeking Treatment for Obesity
|
N/A | |
Completed |
NCT05211063 -
Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders
|
N/A |